MichaelRayPowersMD
Pediatric Pulmonology • Salem, ORProfessor, Pediatrics, Oregon Health and Science University School of Medicine
Dr. Powers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
875 Oak St SE
Salem, OR 97301Phone+1 503-494-8311- Is this information wrong?
Education & Training
Oregon Health & Science UniversityFellowship, Pediatric Pulmonology, 1991- Oregon Health & Science UniversityResidency, Pediatrics, 1985 - 1988
Oregon Health and Science University School of MedicineClass of 1985
Certifications & Licensure
OR State Medical License 1986 - 2025- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 27 citationsFavorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.Ryan C Perkins, Jaclyn Davis, Andrew NeSmith, Julianna Bailey, Michael R. Powers, Nauman Chaudary, Christopher Siracusa, Ahmet Uluer, George M. Solomon, Gregory S. Saw...> ;Annals of the American Thoracic Society. 2021 Sep 1
- 23 citationsLong-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain, Rainald Fischer, Kris De Boeck, Gregory S Sawicki, Philip Chang, Hildegarde Paz-Dia...> ;The Lancet. Respiratory Medicine. 2021 Feb 10
- 29 citationsChanges in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial.Felix Ratjen, Michelle Klingel, Philip Black, Michael R. Powers, Hartmut Grasemann, Melinda Solomon, Scott D. Sagel, Scott H Donaldson, Steven M. Rowe, Margaret Rosenfeld> ;American Journal of Respiratory and Critical Care Medicine. 2018 Aug 15
- Join now to see all
Grant Support
- Regulation Of Vessel Regression In Ischemic RetinopathyNational Eye Institute2006–2011
- Growth Factors In Oxygen Injured Neonatal EyesNational Eye Institute1998–2002
- Growth Factors In Neonatal Hyperoxic Eye And Lung InjuryNational Eye Institute1991–1995
Professional Memberships
- Member
Hospital Affiliations
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
